Tis the season for Amazon (AMZN) to shine as Cyber-Monday and the Christmas shopping season approach. Nevertheless, it’s the company’s cloud computing division - not its massive retail operation - that makes the stock so attractive, said Robert Sharps, portfolio manager for the T. Rowe Price Large Cap Growth Fund (TRLGX). 'We think Amazon Web Services will do about $8 billion in revenue this year and it was growing in the most recent quarter well north of 50% with 20% margins,' said Sharps. 'It’s a huge market opportunity over time and we think they have a long lead on the competition.' Sharps added that he believes over the next few years that cloud computing business alone will be able to justify a value that approaches the current enterprise value of the entire company. Shares of Amazon have surged over 112% thus far in 2015. The T. Rowe Price Large Cap Growth Fund is up 8% year-to-date, according to fund-tracker Morningstar. The fund is currently outperforming 90% of its peers in Morningstar’s large growth category. Sharps is also bullish on Alphabet (GOOGL), which has seen its stock jump over 42% this year. He applauded the company’s plans to better disclose its extra-curricular activities like self-driving cars in the coming year in an effort to give Wall Street more clarity about the company’s operations.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.